Literature DB >> 17228079

Antiplatelet treatment for coronary heart disease.

N Clappers1, M A Brouwer, F W A Verheugt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17228079      PMCID： PMC1861405          DOI： 10.1136/hrt.2005.071209

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

1.  Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement.

Authors:  I Müller; M Seyfarth; S Rüdiger; B Wolf; G Pogatsa-Murray; A Schömig; M Gawaz
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

2.  Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Authors:  S Goldman; J Copeland; T Moritz; W Henderson; K Zadina; T Ovitt; J Doherty; R Read; E Chesler; Y Sako
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

Review 3.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

Authors:  V Fuster; L Badimon; J J Badimon; J H Chesebro
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

5.  Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.

Authors:  A K Pedersen; G A FitzGerald
Journal:  N Engl J Med       Date:  1984-11-08       Impact factor: 91.245

6.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Authors:  Deepak L Bhatt; Keith A A Fox; Werner Hacke; Peter B Berger; Henry R Black; William E Boden; Patrice Cacoub; Eric A Cohen; Mark A Creager; J Donald Easton; Marcus D Flather; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A Pearson; P Gabriel Steg; Steven R Steinhubl; Michael A Weber; Danielle M Brennan; Liz Fabry-Ribaudo; Joan Booth; Eric J Topol
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

7.  Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Authors:  Shlomi Matetzky; Boris Shenkman; Victor Guetta; Michael Shechter; Roy Beinart; Roy Bienart; Ilan Goldenberg; Ilya Novikov; Hanna Pres; Naphtali Savion; David Varon; Hanoch Hod
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

8.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Authors:  A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

9.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

10.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Authors:  S Juul-Möller; N Edvardsson; B Jahnmatz; A Rosén; S Sørensen; R Omblus
Journal:  Lancet       Date:  1992-12-12       Impact factor: 79.321
View more
  12 in total

1.  Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2019-06-22       Impact factor: 2.370

2.  A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle.

Authors:  Maria Zellner; Rita Babeluk; Lene H Jakobsen; Christopher Gerner; Ellen Umlauf; Ivo Volf; Erich Roth; Jens Kondrup
Journal:  J Neural Transm (Vienna)       Date:  2011-03-20       Impact factor: 3.575

3.  Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

4.  Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt).

Authors:  Frederick Palm; Martin Kraus; Anton Safer; Joachim Wolf; Heiko Becher; Armin J Grau
Journal:  BMC Neurol       Date:  2014-10-08       Impact factor: 2.474

5.  Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients.

Authors:  Jayesh H Prajapati; Sibasis Sahoo; Tushar Nikam; Komal H Shah; Bhumika Maheriya; Meena Parmar
Journal:  J Lipids       Date:  2014-11-16

6.  ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).

Authors:  Özcan Başaran; Osman Beton; Volkan Doğan; Mehmet Tekinalp; Ahmet Çağrı Aykan; Ezgi Kalaycıoğlu; İsmail Bolat; Onur Taşar; Özgen Şafak; Macit Kalçık; Mehmet Yaman; İbrahim Altun; Mustafa Özcan Soylu; Cevat Kırma; Murat Biteker
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

7.  Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome.

Authors:  Hsien-Li Huang; Chih-Hung Chen; Chia-Te Kung; Yi-Chen Li; Pei-Hsun Sung; Huey-Ling You; Yu-Hung Lin; Wan-Ting Huang
Journal:  Biomed J       Date:  2019-05-08       Impact factor: 4.910

8.  Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.

Authors:  Manish Jain; Matthieu Zellweger; Aurélien Frobert; Jérémy Valentin; Hubert van den Bergh; Georges Wagnières; Stéphane Cook; Marie-Noelle Giraud
Journal:  Front Physiol       Date:  2016-09-12       Impact factor: 4.566

9.  Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.

Authors:  Sanjeevani Shekhar Deshkar; Govind R Borde; Rupali N Kale; Balasaheb A Waghmare; Asha Biju Thomas
Journal:  Int J Pharm Investig       Date:  2017 Oct-Dec

10.  First Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision.

Authors:  George Rahmani; Jayne Prats; Terrence Norchi; Steven Kates; Veronica McInerney; Jack Woods; Jack Kelly
Journal:  Dermatol Surg       Date:  2018-07       Impact factor: 3.398
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.